Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. - Wikidata - wikimedia - TriplyDB

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.

http://www.wikidata.org/entity/Q35098397

about

Challenges and Opportunities in Drug Delivery for Wound Healing Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review Stem cell therapy for lower extremity diabetic ulcers: where do we stand?Effects of ginsenoside Rb₁ on skin changes Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing β2AR antagonists and β2AR gene deletion both promote skin wound repair processes Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice Cartilage oligometric matrix protein-angiopoietin-1 promotes revascularization through increased survivin expression in dermal endothelial cells of skin grafts in mice.Low-dose radiation and its clinical implications: diabetes.Heme oxygenase-1 accelerates cutaneous wound healing in mice.Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia.Regulation of scar formation by vascular endothelial growth factor.Hyperbaric oxygen therapy for wound healing in diabetic rats: Varying efficacy after a clinically-based protocol.Topical androgen antagonism promotes cutaneous wound healing without systemic androgen deprivation by blocking β-catenin nuclear translocation and cross-talk with TGF-β signaling in keratinocytes.Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing.Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression Aging and diabetes impair the neovascular potential of adipose-derived stromal cells.Functional tissue engineering of ligament healing.Human cell-conditioned media produced under embryonic-like conditions result in improved healing time after laser resurfacing.Factors affecting wound healing.Dopamine regulates angiogenesis in normal dermal wound tissues PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds.Long-term alterations of cytokines and growth factors expression in irradiated tissues and relation with histological severity scoring Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice.Dopamine regulates mobilization of mesenchymal stem cells during wound angiogenesis.Skin wound healing in diabetic β6 integrin-deficient mice.Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice.COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats.Effects of PEMF on microcirculation and angiogenesis in a model of acute hindlimb ischemia in diabetic rats.Nanofiber Microenvironment Effectively Restores Angiogenic Potential of Diabetic Endothelial Cells.Accelerated wound healing mediated by activation of Toll-like receptor 9 Importance of defining experimental conditions in a mouse excisional wound model.14S,21R-dihydroxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds.

P2860

Q26767057-705D4FA4-C56E-4915-A7EC-C3B32A524686 Q26778684-268B36B5-EEB6-4C48-8352-29587491ACE5 Q26799856-21179BEB-0712-4CD1-A098-6902E296D1EC Q26824484-F785B2AE-7C6B-4571-8FA3-3392E12A4A3B Q26828917-21ACDB59-B105-4710-818E-87A888580A4B Q27023354-DB6193FC-F501-4B85-9BBD-0291590FCBC4 Q27302994-854974B6-CB59-412A-947C-E9CAFE8E6358 Q27312663-0EBD525E-81F9-4851-B222-DCBB758A4FB5 Q28074810-1597BE12-C9F4-43BE-B08D-420E095C82CD Q28241438-C79C4FDD-CE78-4755-9F52-B270BCA926F6 Q28260373-B9B6E418-15C8-49E8-A402-1C047CEB892C Q28478087-0CE64419-75CA-476C-B630-643918E7A644 Q28564393-3AB8FE1A-3A9B-4C5E-ACED-22590104193D Q30503408-7677AB37-87C3-4EDD-905C-048F53014292 Q33299822-6DC84CEA-BB86-45AC-B5B7-935DA39BF7B1 Q33334762-4B02C940-A846-46E4-B841-95E61BB71681 Q33460409-EF02514C-466A-4DBD-BD2B-E1B5EC28B33D Q33472763-F219C485-1392-4536-93BF-D09D23536491 Q33605750-6CDBD0F6-FF68-484D-8B50-751C75F8444D Q33699334-A3F1C104-E28D-45D1-A46B-B8E72AE52FFF Q33772279-ADE2D494-890B-4626-A71C-90848A9578BA Q33784618-A75BAC3D-5DEA-46A1-BB50-68FA6671B36A Q33807106-422541A9-C893-481A-AF22-E83640BDFD97 Q33886099-43C02F59-7643-453C-A1BA-03C7A887DB20 Q33888040-49317953-A50B-4778-AA8E-2D59023411D9 Q33953512-ECD3D299-FFEE-454A-9B19-71550E6D0116 Q33993981-37C5FB8A-ECE2-41A4-A8C9-BCEBC4820BA8 Q34032018-52B56425-EC49-4443-BA4A-65D2CCC9CB4B Q34047251-B641FAB0-D304-44AD-B022-9C462C0D73EE Q34117553-6652AD1C-5603-4D66-A544-FA8AAD5FA28A Q34128496-E85DAFE1-1FC1-4CFD-85DF-71A908EB7572 Q34166448-B0713ABB-239C-4DD1-9DA9-D563ABD6C538 Q34240864-CA9498D1-F870-4B1B-8968-36770FF14226 Q34360080-7D163DE4-B956-43EA-8843-B4E40B561FCC Q34362253-D8B0AB93-3E43-44AC-95C4-E1C7AE6A1BA8 Q34404439-79426F02-BB54-48A0-9A6C-D65E3AB52350 Q34440104-827FB63A-574A-42D2-A0BE-E5FFAF882AD8 Q34440785-8B674BF9-9B19-4B6F-9264-08A910D29BD8 Q34463965-ED26945A-294E-44FC-BD91-B0D3D2C23473 Q34575934-FA84A8EE-FDDD-4B93-A7EC-EE4F621FC80A

P2860

Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.

http://www.wikidata.org/entity/Q35098397

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Topical vascular endothelial g ...... ing bone marrow-derived cells.

@ast

Topical vascular endothelial g ...... ing bone marrow-derived cells.

@en

type

label

Topical vascular endothelial g ...... ing bone marrow-derived cells.

@ast

Topical vascular endothelial g ...... ing bone marrow-derived cells.

@en

prefLabel

Topical vascular endothelial g ...... ing bone marrow-derived cells.

@ast

Topical vascular endothelial g ...... ing bone marrow-derived cells.

@en

P1433

Q35098397-7C789263-9100-4CE4-9686-9E9A81896257

P1476

Q35098397-B708DB50-9E5D-471D-A62A-E5C1518C2B9E

P2093

Q35098397-0FF2BC04-D0EF-4AA1-870A-809837FB65D4

Q35098397-179A0500-5028-47E3-8CD3-7BB4BD43775D

Q35098397-1C15288C-FD18-4880-8E57-D219898C5DC5

Q35098397-4F05BC5C-31F0-462D-BD14-92C031477DD0

Q35098397-9C164844-1D50-41E5-AEF8-CA8CFE3437FA

Q35098397-9CF4E13E-052D-4F28-B1C3-CB360D1B7B0C

Q35098397-A6665E92-5C67-4655-B735-12DADFEA12D9

Q35098397-BEDFB3B7-169B-460E-865B-D71DE167269F

Q35098397-F340CA90-D91E-4D09-9482-E41C5BF2DBB0

P2860

Q35098397-050E9147-E839-405B-8406-74206F015935

Q35098397-0731076C-E83A-4C3D-93FC-5E1EF7A54DBC

Q35098397-0A18331C-6220-4608-8B0E-82DE0735D91F

Q35098397-0BFE5995-5AE5-4085-86B0-36F9B1EE4EAF

Q35098397-0D33DE70-588B-4B71-9AC1-5A1931DDC9E2

Q35098397-0E5F1F94-7CFA-426D-B5A9-038E1D24C497

Q35098397-135F447E-CF83-4214-9101-AAD87673537B

Q35098397-1532263F-8ADA-4EDC-BCFE-A376156B0D36

Q35098397-1719C71F-F8A8-4D43-B98E-FA9718BE2570

Q35098397-202E57D1-3696-4D82-85F8-77FA391FD682

P304

Q35098397-17D637B7-F500-4080-A4C8-414FFAB73A17

P31

Q35098397-6AAB14E1-3641-4F50-A489-7EB522D710B3

P356

Q35098397-D9118F66-67DF-4844-B1B4-DCF2E7393BA2

P407

Q35098397-34613C89-635F-4333-807C-6127E214F8FE

P433

Q35098397-27248BA3-6EEE-44DA-A9F4-D42A089BF764

P478

Q35098397-2DA4E4E3-48B7-4EF1-B0C7-31C04EE5A239

P577

Q35098397-90EC7BCD-AF3B-48B5-B5F8-07C6E27982C0

P5875

Q35098397-8EEEA283-47C7-45EA-BD75-5458702DC433

P698

Q35098397-3A4E31AC-8DB4-4BCA-A0E4-0F65898CDAD4

P921

Q35098397-2EB7FC9F-69BC-46AB-A2EA-0D19C3DE5A3E

Q35098397-D40C3097-64FB-44E7-8C6C-2F4DE43A610F

P932

Q35098397-918DE13E-9964-4A3D-8727-AD1E454F0A43

P356

S0002-9440(10)63754-6

P1433

The American Journal of Pathology

P1476

Topical vascular endothelial g ...... ing bone marrow-derived cells.

@en

P2093

Catherine R Pelo

http://www.w3.org/2001/XMLSchema#string

Geoffrey C Gurtner

http://www.w3.org/2001/XMLSchema#string

Hope G Steinmetz

http://www.w3.org/2001/XMLSchema#string

Kirit A Bhatt

http://www.w3.org/2001/XMLSchema#string

Matthew Callaghan

http://www.w3.org/2001/XMLSchema#string

Nicholas Bastidas

http://www.w3.org/2001/XMLSchema#string

Oren M Tepper

http://www.w3.org/2001/XMLSchema#string

Robert D Galiano

http://www.w3.org/2001/XMLSchema#string

Stuart Bunting

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Isolation of putative progenitor endothelial cells for angiogenesis

Reversal of experimental diabetic neuropathy by VEGF gene transfer

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Mechanisms of angiogenesis and arteriogenesis

Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

P304

1935-1947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63754-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8544093

http://www.w3.org/2001/XMLSchema#string

P698

15161630

http://www.w3.org/2001/XMLSchema#string

P921

P932

1615774

http://www.w3.org/2001/XMLSchema#string